|
| |||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
|
| Major Depressive Disorder Study for those who have failed treatment (ADAPT) (Now Enrolling!) A placebo-controlled study of Aripirazole adjunctive to antidepressant therapy. To be eligible individuals must have failed one to three antidepressant therapies, one of which must be current. Call us at 214-648-HELP(4357) for more information. Takeda Insomnia (Now Enrolling!) Call us at 214-648-HELP(4357) for more information. Abilify for Cogntive Dysfunction (Now Enrolling!) Call us at 214-648-HELP(4357) for more information. Implementation of Algorithms for Computerized Treatments of Depression (IMPACTS) Texas Implementation of Medication Algorithms (TIMA)
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Copyright 2009. The University of Texas Southwestern Medical Center at Dallas 5323 Harry Hines Boulevard, Dallas, Texas 75390. Telephone 214-648-3111 |